Ryan Maynard - Jun 29, 2021 Form 4 Insider Report for IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

Role
Director
Signature
/s/ Ryan Maynard
Stock symbol
IOVA
Transactions as of
Jun 29, 2021
Transactions value $
$0
Form type
4
Date filed
7/1/2021, 04:18 PM
Next filing
Jun 2, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IOVA Stock Option (right to buy) Award $0 +35K $0.00 35K Jun 29, 2021 Common Stock 35K $26.33 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options are exercisable in four equal quarterly installments of 8,750 each following the date of grant, such that the options will be fully vested and exercisable on June 29, 2022.